Race for a COVID-19 antibody treatment halted
Disease control
Terminated
This study tested if a lab-made antibody drug called SCTA01 could help hospitalized adults with severe COVID-19 get better faster. It compared the drug plus standard care against a placebo plus standard care. The trial was designed in two parts to find the best dose and then test…
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC